GE HealthCare Technologies Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GEHC research report →
Companywww.gehealthcare.com
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
- CEO
- Peter J. Arduini
- IPO
- 2022
- Employees
- 53,000
- HQ
- Chicago, IL, US
Price Chart
Valuation
- Market Cap
- $29.23B
- P/E
- 19.47
- P/S
- 1.46
- P/B
- 2.75
- EV/EBITDA
- 11.83
- Div Yield
- 0.22%
Profitability
- Gross Margin
- 42.55%
- Op Margin
- 12.46%
- Net Margin
- 7.54%
- ROE
- 14.77%
- ROIC
- 6.71%
Growth & Income
- Revenue
- $20.63B · 4.84%
- Net Income
- $2.08B · 4.57%
- EPS
- $4.56 · 4.35%
- Op Income
- $2.76B
- FCF YoY
- -2.84%
Performance & Tape
- 52W High
- $89.77
- 52W Low
- $58.75
- 50D MA
- $68.54
- 200D MA
- $75.64
- Beta
- 0.87
- Avg Volume
- 4.46M
Get TickerSpark's AI analysis on GEHC
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 15, 26 | Rackliffe Philip | other | 16,458 |
| May 15, 26 | Bankes Jeannette | other | 5,535 |
| May 12, 26 | Hochman Rodney F | buy | 1,618 |
| May 8, 26 | Yang Watkin Phoebe L. | buy | 1,000 |
| May 7, 26 | Yang Watkin Phoebe L. | other | 3,586 |
| May 7, 26 | CULP H LAWRENCE JR | other | 4,157 |
| May 7, 26 | CULP H LAWRENCE JR | other | 3,586 |
| May 7, 26 | Hochman Rodney F | other | 2,689 |
| May 7, 26 | Hochman Rodney F | other | 3,586 |
| May 7, 26 | LESJAK CATHERINE A | other | 3,586 |
Our GEHC Coverage
View all →
GE HealthCare Technologies Inc. (GEHC) falls on deep earnings analysis
GE HealthCare Technologies Inc. (GEHC) falls after a closer look at earnings shows a profit miss, margin pressure, and a lowered full-year outlook despite solid revenue and backlog growth. This deep-dive analysis breaks down segment performance, inflation headwinds, and why investors focused on guidance rather than sales.
GE HealthCare Technologies Inc. (GEHC) falls 14% on Q1 miss
GE HealthCare Technologies Inc. (GEHC) falls sharply after its first-quarter report missed profit estimates and management cut full-year guidance. Revenue beat expectations, but inflationary cost pressure and weaker profit outlook overshadowed the top-line strength, triggering heavy selling on above-average volume.
GE HealthCare (GEHC): Backlog and PDx Growth vs. Margin Pressure
GE HealthCare offers a balanced medtech setup with a $21.8B backlog, growing pharmaceutical diagnostics, and solid free cash flow, but tariffs and margin pressure are still weighing on results.
Want a deeper read on GEHC?
Generate a full analyst-grade report — bull / bear case, price targets, valuation depth, and a complete financial breakdown.